Royal Biological Co., LTD Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Wuxi China

Organization Overview

First Clinical Trial
2011
NCT01406509
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Royal (Wuxi) Biological Co., LTD